Seven Eight Capital’s Cano Health, Inc. CANO Stock Holding History

Seven Eight Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-890	Closed	-$1.13M	–	719
2021 Q3	$1.13M	Buy	+890	New	+$1.08M	0.11%	274

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Seven Eight Capital's CANO Position: Q4 2021 in Review

Seven Eight Capital sold out of Cano Health, Inc. (CANO) in Q4 2021, closing a stake of 890 shares — an estimated $1.13M sold.

Seven Eight Capital first reported a position in CANO in Q3 2021 and held it in 1 quarter. The position peaked at $1.13M in Q3 2021. 130 funds tracked by Wall St. Rank hold CANO as of Q4 2021.

Seven Eight Capital reported no remaining Cano Health, Inc. position as of Q4 2021 after selling out during the quarter.
Seven Eight Capital sold 890 Cano Health, Inc. shares in Q4 2021, an estimated $1.13M.
Seven Eight Capital first reported a position in Cano Health, Inc. in Q3 2021 and held it in 1 quarter.
Seven Eight Capital's Cano Health, Inc. position peaked at $1.13M in Q3 2021.
130 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2021.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.